271 related articles for article (PubMed ID: 36121081)
21. Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions.
Nida S; Srinivisan H; Pandurangan AK; Waseem M
J Environ Pathol Toxicol Oncol; 2022; 41(1):85-98. PubMed ID: 35378006
[TBL] [Abstract][Full Text] [Related]
22. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
Taher T; Sheikh AB; Anwar F; Khosa F
Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
[TBL] [Abstract][Full Text] [Related]
24. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
[TBL] [Abstract][Full Text] [Related]
25. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.
Vogrig A; Janes F; Gigli GL; Curcio F; Negro ID; D'Agostini S; Fabris M; Valente M
Clin Neurol Neurosurg; 2021 Sep; 208():106839. PubMed ID: 34325334
[TBL] [Abstract][Full Text] [Related]
26. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
27. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
28. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
29. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
31. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.
Williams A; Branscome H; Khatkar P; Mensah GA; Al Sharif S; Pinto DO; DeMarino C; Kashanchi F
J Neurovirol; 2021 Oct; 27(5):667-690. PubMed ID: 34581996
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
34. Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.
Martins M; Pereira A; Teixeira A; Lima D; Lopes N; Amaral-Silva M; Seixo I; Miguéns AC
Cureus; 2022 Dec; 14(12):e32655. PubMed ID: 36654564
[TBL] [Abstract][Full Text] [Related]
35. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19.
Crook H; Ramirez A; Hosseini A; Vavougyios G; Lehmann C; Bruchfeld J; Schneider A; D'Avossa G; Lo Re V; Salmoiraghi A; Mukaetova-Ladinska E; Katshu M; Boneschi FM; Håkansson K; Geerlings M; Pracht E; Ruiz A; Jansen JFA; Snyder H; Kivipelto M; Edison P
Brain Connect; 2023 May; 13(4):178-210. PubMed ID: 36719785
[No Abstract] [Full Text] [Related]
36. Neurological manifestations and comorbidity associated with COVID-19: an overview.
Kumar M; Thakur AK
Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
[TBL] [Abstract][Full Text] [Related]
37. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
38. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
39. Does SARS-Cov-2 invade the brain? Translational lessons from animal models.
Natoli S; Oliveira V; Calabresi P; Maia LF; Pisani A
Eur J Neurol; 2020 Sep; 27(9):1764-1773. PubMed ID: 32333487
[TBL] [Abstract][Full Text] [Related]
40. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
